Teva Pharmaceutical Industries Limited TEVAN.MX Stock
Teva Pharmaceutical Industries Limited Price Chart
Teva Pharmaceutical Industries Limited TEVAN.MX Financial and Trading Overview
Contents
Teva Pharmaceutical Industries Limited stock price | 232 MXN |
Previous Close | 126.5 MXN |
Open | 126.5 MXN |
Bid | 0 MXN x 18900 |
Ask | 133 MXN x 100000 |
Day's Range | 0 - 0 MXN |
52 Week Range | 0 - 222.78 MXN |
Volume | 1.1K MXN |
Avg. Volume | 342 MXN |
Market Cap | 131.18B MXN |
Beta (5Y Monthly) | 1.180985 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -11.399 MXN |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
TEVAN.MX Valuation Measures
Enterprise Value | 161.38B MXN |
Trailing P/E | N/A |
Forward P/E | N/A |
PEG Ratio (5 yr expected) | N/A |
Price/Sales (ttm) | 8.789313 |
Price/Book (mrq) | 18.032787 |
Enterprise Value/Revenue | 10.812 |
Enterprise Value/EBITDA | 42.647 |
Trading Information
Teva Pharmaceutical Industries Limited Stock Price History
Beta (5Y Monthly) | 1.180985 |
52-Week Change | -21.47% |
S&P500 52-Week Change | 20.43% |
52 Week High | 222.78 MXN |
52 Week Low | 0 MXN |
50-Day Moving Average | 172.24 MXN |
200-Day Moving Average | 172.24 MXN |
TEVAN.MX Share Statistics
Avg. Volume (3 month) | 342 MXN |
Avg. Daily Volume (10-Days) | 427 MXN |
Shares Outstanding | 1.1B |
Float | 1.11B |
Short Ratio | N/A |
% Held by Insiders | 0% |
% Held by Institutions | 51.06% |
Shares Short | N/A |
Short % of Float | N/A |
Short % of Shares Outstanding | N/A |
Dividends & Splits
Trailing Annual Dividend Rate | 0 |
Trailing Annual Dividend Yield | 0% |
5 Year Average Dividend Yield | N/A |
Payout Ratio | N/A |
Last Split Factor |
Financial Highlights
Fiscal Year
Fiscal Year Ends | December 31, 2022 |
Most Recent Quarter (mrq) | March 31, 2023 |
Next Fiscal Year End | December 31, 2023 |
Profitability
Profit Margin | -10.74% |
Operating Margin (ttm) | 16.71% |
Gross Margin | 45.66% |
EBITDA Margin | 25.35% |
Management Effectiveness
Return on Assets (ttm) | 3.44% |
Return on Equity (ttm) | -17.93% |
Income Statement
Revenue (ttm) | 14.92B MXN |
Revenue Per Share (ttm) | 13.42 MXN |
Quarterly Revenue Growth (yoy) | 0% |
Gross Profit (ttm) | 6.97B MXN |
EBITDA | 3.78B MXN |
Net Income Avi to Common (ttm) | -1603000064 MXN |
Diluted EPS (ttm) | -11.399 |
Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
Total Cash (mrq) | 2.14B MXN |
Total Cash Per Share (mrq) | 1.91 MXN |
Total Debt (mrq) | 21.04B MXN |
Total Debt/Equity (mrq) | 244.29 MXN |
Current Ratio (mrq) | 1.105 |
Book Value Per Share (mrq) | 7.015 |
Cash Flow Statement
Operating Cash Flow (ttm) | 1.49B MXN |
Levered Free Cash Flow (ttm) | 2.62B MXN |
Profile of Teva Pharmaceutical Industries Limited
Country | Mexico |
State | N/A |
City | Tel Aviv |
Address | 124 Dvora Hanevi’a Street |
ZIP | 6944020 |
Phone | 972 3 914 8213 |
Website | https://www.tevapharm.com |
Industry | Drugs - Generic |
Sector(s) | Healthcare |
Full Time Employees | 34004 |
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, Israel, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage forms, including tablets, capsules, injectables, inhalants, liquids, transdermal patches, ointments, and creams. It also manufactures and sells active pharmaceutical ingredients, as well as provides contract manufacturing services; and operates an out-licensing platform that offers a portfolio of products to other pharmaceutical companies. In addition, it focuses on the central nervous system (CNS), pain, respiratory, and oncology areas. The company's products portfolio in the CNS field comprises Copaxone for the treatment of relapsing forms of multiple sclerosis; AJOVY for the preventive treatment of migraine in adults; and AUSTEDO for the treatment of neurodegenerative and movement disorders associated with Huntington's disease and tardive dyskinesia; respiratory therapeutic area includes ProAir RespiClick, QVAR, ProAir Digihaler, AirDuo Digihaler, ArmonAir Digihaler, BRALTUS, CINQAIR/CINQAERO, DuoResp Spiromax, and AirDuo RespiClick/ArmonAir RespiClick for the treatment of asthma and chronic obstructive pulmonary disease; and oncology therapeutic field consists of Bendeka, Treanda, Granix, Trisenox, Lonquex, and Tevagrastim/Ratiograstim. Teva Pharmaceutical Industries Limited has a collaboration MedinCell for the development and commercialization of multiple long-acting injectable products, a risperidone suspension for the treatment of patients with schizophrenia. The company was founded in 1901 and is headquartered in Tel Aviv, Israel.
Q&A For Teva Pharmaceutical Industries Limited Stock
What is a current TEVAN.MX stock price?
Teva Pharmaceutical Industries Limited TEVAN.MX stock price today per share is 232 MXN.
How to purchase Teva Pharmaceutical Industries Limited stock?
You can buy TEVAN.MX shares on the Mexico exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Teva Pharmaceutical Industries Limited?
The stock symbol or ticker of Teva Pharmaceutical Industries Limited is TEVAN.MX.
Which industry does the Teva Pharmaceutical Industries Limited company belong to?
The Teva Pharmaceutical Industries Limited industry is Drugs - Generic.
How many shares does Teva Pharmaceutical Industries Limited have in circulation?
The max supply of Teva Pharmaceutical Industries Limited shares is 1.04B.
What is Teva Pharmaceutical Industries Limited Price to Earnings Ratio (PE Ratio)?
Teva Pharmaceutical Industries Limited PE Ratio is now.
What was Teva Pharmaceutical Industries Limited earnings per share over the trailing 12 months (TTM)?
Teva Pharmaceutical Industries Limited EPS is -11.399 MXN over the trailing 12 months.
Which sector does the Teva Pharmaceutical Industries Limited company belong to?
The Teva Pharmaceutical Industries Limited sector is Healthcare.